Morgan Stanley cuts Microsoft stock target, overweight rating amid concerns
Morgan Stanley (NYSE:MS) adjusted its outlook on shares of Microsoft stock (NASDAQ:MSFT), reducing the price target to $540 ...
Oppenheimer lifts Tarsus stock target, impressed by execution and ocular rosacea potential
Oppenheimer updated its outlook on Tarsus Pharmaceuticals (NASDAQ:TARS), a $1.8 billion market cap biotechnology company, ...
5 Things to Know Before the Stock Market Opens
Netflix stock soars on better-than-expected results, U.S. stock futures gain as investors evaluate moves by President Donald Trump, and Oracle shares jump on major AI infrastructure investment with ...